300633 开立医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.5114.55415.44214.51613.364
总资产报酬率 ROA (%)1.1293.52312.42411.2679.379
投入资产回报率 ROIC (%)1.3314.14014.36013.22911.268

边际利润分析
销售毛利率 (%)62.08463.78367.71166.86667.382
营业利润率 (%)3.5756.03622.39421.69614.929
息税前利润/营业总收入 (%)-0.0284.11220.24119.97318.229
净利润/营业总收入 (%)4.8777.07121.43320.98017.115

收益指标分析
经营活动净收益/利润总额(%)24.94399.87696.02389.84591.386
价值变动净收益/利润总额(%)5.8243.462-2.7101.3935.902
营业外收支净额/利润总额(%)0.965-1.137-0.208-0.12715.163

偿债能力分析
流动比率 (X)3.3052.7464.6173.3553.836
速动比率 (X)2.3052.1433.6822.6693.044
资产负债率 (%)22.45727.93416.58422.69722.023
带息债务/全部投入资本 (%)7.60211.7511.8928.8004.165
股东权益/带息债务 (%)1,187.118731.7885,093.5281,016.0202,238.482
股东权益/负债合计 (%)345.303257.992502.980340.596354.069
利息保障倍数 (X)0.008-2.215-9.606-11.77828.865

营运能力分析
应收账款周转天数 (天)37.54934.50531.65941.57156.642
存货周转天数 (天)354.665292.342274.978294.299286.965